Skip to content

Stoke Therapeutics, Inc. STOK Reduction In Carrying Amount Of Operating Lease Right Of Use Assets

Reduction In Carrying Amount Of Operating Lease Right Of Use Assets at other companies

Extreme Networks logo
Extreme NetworksEXTR
$2.61M+4.6%
nLIGHT, Inc. logo
nLIGHT, Inc.LASR
$723K+253%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$3.11M-20.9%
RingCentral logo
RingCentralRNG
$6.42M-8.1%
Netscout Systems logo
Netscout SystemsNTCT
$2.37M-7.3%
Gartner logo
GartnerIT
$14.89M-16.0%

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$1.94B+436%
Enterprise value$1.79B+1,855%
P/S60.4×+58.5×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0.0×
Current ratio+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept stok:ReductionInCarryingAmountOfOperatingLeaseRightOfUseAssets.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets?
Stoke Therapeutics, Inc. (STOK) reported reduction in carrying amount of operating lease right of use assets of $608K in Q1 2026.
How has Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets changed year-over-year?
Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets increased by 1.5% year-over-year, from $599K to $608K.
What is the long-term trend for Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets?
Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s reduction in carrying amount of operating lease right of use assets has grown at a 17.7% compound annual growth rate (CAGR), from $1.26M to $2.41M.
What does reduction in carrying amount of operating lease right of use assets mean?
This represents the periodic reduction in the book value of right-of-use assets associated with operating leases, typically reflecting amortization or depreciation over the lease term. It is a non-cash adjustment that reconciles net income with cash flow from operations. Tracking this helps analysts understand the company's long-term commitment to leased infrastructure and its impact on cash flow.